MR
Michael R Megna sold $1.1M of KNSA stock
Michael R Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals International, plc (KNSA), sold 11,280 shares of KNSA stock worth $1.1M, per an SEC Form 4 filed Nov 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 9, 2026, 3 days before it was made public.
KNSA has moved -2.5% since the trade date, from $98.76 to $96.33 (Nov 13, 2026 close).
- Traded
- Nov 9, 2026
- Disclosed
- Nov 12, 2026
- Filing delay
- 3 days
- Price since
- -2.5%
- Role
- Chief Accounting Officer
- Source
- SEC Form 4